Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer

被引：0

作者：

Barreto, Savio George ^{[1
,2
]}

Shrikhande, Shailesh, V ^{[3
]}

Sirohi, Bhawna ^{[4
]}

机构：

[1] Flinders Med Ctr, Div Surg & Perioperat Med, Bedford Pk, Adelaide, SA, Australia

[2] Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia

[3] Tata Mem Hosp, Dept Surg Oncol, GI & HPB Serv, Mumbai, Maharashtra, India

[4] Apollo Proton Canc Ctr, Dept Med Oncol, Chennai, Tamil Nadu, India

来源：

INDIAN JOURNAL OF SURGICAL ONCOLOGY | 2024年 / 15卷 / SUPPL 2期

关键词：

Neoadjuvant therapy; Pancreatic cancer; Surgical resection; INDUCTION CHEMOTHERAPY; CONSENSUS STATEMENT; TUMOR RESPONSE; ADENOCARCINOMA; GEMCITABINE; FOLFIRINOX; OUTCOMES; CHEMORADIOTHERAPY; RADIOTHERAPY; RADIATION;

D O I：

10.1007/s13193-021-01361-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In this perspective, we present our assessment of all of the known accumulated evidence on the role of neoadjuvant therapy in the management of borderline resectable pancreatic cancer highlighting the gaps in the data, the current regimens used and providing a brief insight into the way forward.

引用

页码：249 / 254

页数：6

共 42 条

[1] Surgical Outcome Results From SWOG S1505 A Randomized Clinical Trial of mFOLFIRINOX Versus Gemcitabine/Nab-paclitaxel for Perioperative Treatment of Resectable Pancreatic Ductal Adenocarcinoma [J].

Ahmad, Syed A. ;

Duong, Mai ;

Sohal, Davendra P. S. ;

Gandhi, Namita S. ;

Beg, Muhammad Shaalan ;

Wang-Gillam, Andrea ;

Wade, James L., III ;

Chiorean, Elena Gabriela ;

Guthrie, Katherine A. ;

Lowy, Andrew M. ;

Philip, Philip A. ;

Hochster, Howard S. .

ANNALS OF SURGERY, 2020, 272 (03) :481-486

[2] Pancreatic Ductal Adenocarcinoma Radiology Reporting Template: Consensus Statement of the Society of Abdominal Radiology and the American Pancreatic Association [J].

Al-Hawary, Mahmoud M. ;

Francis, Isaac R. ;

Chari, Suresh T. ;

Fishman, Elliot K. ;

Hough, David M. ;

Lu, David S. ;

Macari, Michael ;

Megibow, Alec J. ;

Miller, Frank H. ;

Mortele, Koenraad J. ;

Merchant, Nipun B. ;

Minter, Rebecca M. ;

Tamm, Eric P. ;

Sahani, Dushyant V. ;

Simeone, Diane M. .

GASTROENTEROLOGY, 2014, 146 (01) :291-+

[3] Neoadjuvant FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer: An intention to treat analysis [J].

Barenboim, Alex ;

Lahat, Guy ;

Geva, Ravit ;

Nachmany, Ido ;

Nakache, Richard ;

Goykhman, Yaacov ;

Brazowski, Eli ;

Rosen, Galia ;

Isakov, Ofer ;

Wolf, Ido ;

Klausner, Joseph M. ;

Lubezky, Nir .

EJSO, 2018, 44 (10) :1619-1623

[4] Detecting tumour response and predicting resectability after neoadjuvant therapy for borderline resectable and locally advanced pancreatic cancer [J].

Barreto, Savio G. ;

Loveday, Benjamin ;

Windsor, John A. ;

Pandanaboyana, Sanjay .

ANZ JOURNAL OF SURGERY, 2019, 89 (05) :481-487

[5] Justifying vein resection with pancreatoduodenectomy [J].

Barreto, Savio G. ;

Windsor, John A. .

LANCET ONCOLOGY, 2016, 17 (03) :E118-E124

[6] Neoadjuvant Therapy in Pancreatic Cancer: An Emerging Strategy [J].

Bittoni, Alessandro ;

Santoni, Matteo ;

Lanese, Andrea ;

Pellei, Chiara ;

Andrikou, Kalliopi ;

Stefano, Cascinu .

GASTROENTEROLOGY RESEARCH AND PRACTICE, 2014, 2014

[7] Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS) [J].

Bockhorn, Maximilian ;

Uzunoglu, Faik G. ;

Adham, Mustapha ;

Imrie, Clem ;

Milicevic, Miroslav ;

Sandberg, Aken A. ;

Asbun, Horacio J. ;

Bassi, Claudio ;

Buechler, Markus ;

Charnley, Richard M. ;

Conlon, Kevin ;

Cruz, Laureano Fernandez ;

Dervenis, Christos ;

Fingerhutt, Abe ;

Friess, Helmut ;

Gouma, Dirk J. ;

Hartwig, Werner ;

Lillemoe, Keith D. ;

Montorsi, Marco ;

Neoptolemos, John P. ;

Shrikhande, Shailesh V. ;

Takaori, Kyoichi ;

Traverso, William ;

Vashist, Yogesh K. ;

Vollmer, Charles ;

Yeo, Charles J. ;

Izbicki, Jakob R. .

SURGERY, 2014, 155 (06) :977-988

[8] Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement [J].

Callery, Mark P. ;

Chang, Kenneth J. ;

Fishman, Elliot K. ;

Talamonti, Mark S. ;

Traverso, L. William ;

Linehan, David C. .

ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (07) :1727-1733

[9] Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer.: Definitive results of the 2000-01 FFCD/SFRO study [J].

Chauffert, B. ;

Mornex, F. ;

Bonnetain, F. ;

Rougier, P. ;

Mariette, C. ;

Bouche, O. ;

Bosset, J. F. ;

Aparicio, T. ;

Mineur, L. ;

Azzedine, A. ;

Hammel, P. ;

Butel, J. ;

Stremsdoerfer, N. ;

Maingon, P. ;

Bedenne, L. .

ANNALS OF ONCOLOGY, 2008, 19 (09) :1592-1599

[10] Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer [J].

Chuong, Michael D. ;

Frakes, Jessica M. ;

Figura, Nicholas ;

Hoffe, Sarah E. ;

Shridhar, Ravi ;

Mellon, Eric A. ;

Hodul, Pamela J. ;

Malafa, Mokenge P. ;

Springett, Gregory M. ;

Centeno, Barbara A. .

JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2016, 7 (02) :221-227

← 1 2 3 4 5 →